СЛОВО,abstract,infections,in,childhood,play,an,essential,role,the,pathogenesis,of,cognitive,and,psycho-emotional,disorders,one,possible,mechanisms,these,impairments,is,changes,functional,properties,nmda,ampa,glutamate,receptors,brain,we,suggest,that,bacterial,during,early,life,period,which,critical,for,excitatory,synapse,maturation,can,affect,subunit,composition,present,study,investigated,effect,repetitive,lipopolysaccharide,lps,intraperitoneal,ip,administration,25 μg/kg/day,on,p14,16,18,mimicking,infectious,disease,expression,subunits,young,rats,revealed,a,substantial,decrease,glun2b,hippocampus,at,p23,using,western,blot,analysis,real-time,polymerase,chain,reaction,assay,moderate,were,also,found,glun1,glun2a,glua1,mrna,lps-treated,exhibited,decreased,exploratory,locomotor,activity,open,field,test,impairment,spatial,learning,morris,water,maze,behavioral,accompanied,by,significant,reduction,long-term,hippocampal,synaptic,potentiation,our,data,indicate,lps-treatment,alters,ionotropic,receptor,gene,disturbs,plasticity,behavior,prolonged,exposure,to,manganese,mn,may,lead,toxic,effects,central,nervous,system,cns,underlying,neuronal,death,from,are,not,well,understood,but,undoubtedly,involve,inflammatory,processes,aim,this,was,explore,long-lasting,intranasal,focusing,catecholamine,dopamine,norepinephrine,levels,striatum,it,instillation,mncl2,solution,once,day,90,days,leads,impaired,movement,gait,observed,concentration,increased,30,%,220,24,dopac,35,reduced,190,with,simultaneously,observation,cytokine,both,assayed,cytokines,il-1β,tnf-α,there,3-fold,increase,iba-1,2-fold,nfκb,dramatic,ikb,taken,together,high,dose,induces,neuroinﬂammation,neurotransmission,disturbance,specific,each,studied,region,shortly,after,syphilis,appeared,europe,time,columbus’,voyage,new,world,big,pox,as,often,known,became,serious,issue,russia,diagnosis,treatment,prevention,members,russian,royal,family,made,aware,adolescence,onward,czar,peter,great,had,many,sexual,contacts,could,have,contracted,any,number,sexually,transmitted,diseases,stds,quite,common,his,era,nevertheless,contributions,analyzed,available,sources,contemporary,doctors,later,medical,analyses,reveal,no,evidence,he,or,other,std,most,likely,died,acute,renal,failure,due,urinary,tract,obstruction,upper,respiratory,world's,etiologic,agents,behind,urtis,fact,diverse,set,pathogens,such,influenza,parainfluenza,adenovirus,rhinovirus,others,more,than,200,be,involved,differential,viral,sometimes,complicated,their,diversity,similarity,clinical,presentation,work,devoted,development,method,enables,simultaneous,detection,six,urti,iav,ibv,rsv,hadv,hpiv2,hpiv3,antibody,microarray,technology,utilized,accomplish,preparation,protein,microchip,creation,produced,characterized,selected,approximately,50,monoclonal,antibodies,aforementioned,optimal,pair,created,its,core,working,conditions,optimized,balance,between,convenience,maximal,sensitivity,mind,one-step,approach,developed,accomplishing,elisa-like,sandwich,interaction,manufactured,reference,strains,used,establish,lower,limits,lod,025 ng/ml,total,viruses,ranged,1,2 ng/ml,slightly,better,those,standard,elisa,inferior,pcr,overall,believe,good,alternative,existing,methods,allowing,relatively,quick,overnight,inexpensive,screening,several,design,conducive,further,panel,expanded,include,fullerene,c60,has,potential,application,various,fields,biomedicine,including,reactive,oxygen,species,ros,scavenging,inhibiting,tumours,inactivating,bacteria,elaboration,diagnostic,targeted,drug,delivery,tools,however,hydrophobicity,molecule,impedes,practical,use,therefore,actuality,research,functionalisation,fullerenes,leading,amphiphilic,derivatives,remains,important,water-soluble,carboxylated,derivative,c60ccooh23,extensive,biomedical,investigation,compound,namely,binding,human,serum,albumin,hsa,radical,diphenylpicrylhydrazyl,dpph,photodynamic,cytotoxicity,embryonic,kidney,hek293,cell,line,erythrocytes',haemolysis,platelet,aggregation,genotoxicity,peripheral,mononuclear,cells,pbmc,conducted,moreover,dynamic,structural,characteristics,c60ccooh23–h2o,binary,obtained,molecular,md,size,distribution,associates,measured,aims,single-center,retrospective,evaluated,whether,level,different,checkpoint,molecules,bone,marrow,biopsies,course,patients,myelodysplastic,syndrome,mds,results,consecutive,cohort,55,treated,center,2003,2018,technique,able,detect,following,antigens,pd-1,pd-l1,pd-l2,lag-3,gal-9,tim-3,cd80,association,3-year,relapse-free,survival,time-to-progression,intensive,100%,cases,follow-up,progression,seen,729%,521%,low,p004,ctla4,ligands,co-expressed,majority,general,ligand,associated,incidence,672%,progressed,while,group,only,333%,p0059,tim3,blasts,risk,according,ipss,ipss-r,scales,conclusions,preliminary,underlined,heterogeneous,immune,warrants,studies,define,heterogeneity,develop,approaches,background,covid-19,pandemic,broadly,disrupted,non-invasive,stimulation,nibs,rapid,onset,societal,disruption,evolving,regulatory,restrictions,allowed,systematic,planning,how,continue,throughout,restarted,abated,urgency,provide,intervention,neurological,mental,health,indications,catalyst,fundamental,dampened,parallel,efforts,address,life-threatening,aspects,rather,need,heightened,mitigate,consequences,related,objective,facilitate,re-establishment,access,services,operations,current,future,outbreaks,discuss,framework,balancing,importance,safety,considerations,addressing,needs,all,stakeholders,focus,transcranial,magnetic,tms,intensity,electrical,tes,-,direct,tdcs,alternating,tacs,consensus,paper,provides,guidelines,practices,managing,reopening,clinics,laboratories,through,immediate,ongoing,stages,document,reflects,experts,domain-relevant,expertise,spanning,basic,–,international,perspective,outline,resources,optimization,accommodations,demographics,model,based,three,phases,impact,11-step,checklist,removing,streamlining,in-person,protocols,incorporating,telemedicine,covid-19-associated,adverse,events,proposed,recommendations,implementing,social,distancing,sterilization,equipment,positive,populations,comorbidities,regarding,resource,outlined,specifically,sub-populations,pediatric,stroke,addiction,elderly,numerous,case-examples,across,described,conclusion,evident,urgent,maintain,anticipating,waves,robust,structured,strategy,anticipated,challenges,maintaining,scientific,rigor,genetic,markers,determine,prognosis,multiple,sclerosis,ms,still,limited,galanin,polymorphism,rs948854,been,demonstrated,earlier,objectives,confirm,findings,distinct,previously,candidates,stratification,assess,rate,severity,score,msss,age,armss,along,index,pi,minor,allele,confirming,proportion,msss  5,among,g,carriers,genotypes,ag,gg,compared,aa,genotype,furthermore,correlated,value,late,years,collectively,support,contribution,summary,purpose,describe,analyze,patient,recurrent,idiopathic,exudative,polymorphous,vitelliform,maculopathy,aepvm,followed,detail,propose,algorithm,observational,adult,male,diagnosed,who,two,relapses,12-month,eight,initial,review,charts,multimodal,imaging,electrophysiology,repeatedly,underwent,complete,ophthalmic,examinations,best-corrected,visual,acuity,testing,bcva,slit-lamp,fundus,digital,photography,time-domain,optical,coherence,tomography,oct,2009,stratus,carl,zeiss,meditec,usa,spectral-domain,2017–2018,spectralis-oct,heidelberg,engineering,germany,autofluorescence,faf,fluorescein,angiography,fa,indocyanine,green,icga,hra2,microperimetry,mp-1,microperimeter,nidek,japan,laser,flare,photometry,kowa,fm-600,performed,main,outcome,measures,features,rare,case,report,25-year-old,caucasian,typical,serous,neuroepithelial,detachment,irregular,retinal,elevations,ophthalmoscopically,resembling,folds,subsequent,subretinal,accumulation,characteristic,yellow–white,deposits,rarely,even,yet,reported,indocyanine-,fluorescein-negative,intraretinal,cystic,optic,disc,hyperfluorescence,choroidal,thickness,lack,recovery,very,slow,anatomical,improvement,bimonthly,evaluation,sd-oct,informative,demonstrating,evolution,pathological,signs,chronic,condition,uncertain,outcomes,variable,presentations,depending,stage,manifestations,pathologic,process,overlap,should,occurs,slowly,if,recommended,allogeneic,hematopoietic,transplantation,hct,high-risk,t,lymphoblastic,leukemia,t-all,without,hla-identical,donor,haploidentical,haplo-,becoming,source,stem,donation,scarce,predictive,factors,setting,identified,122,adults,20%,female,median,31,range,68,haplo-hct,post-transplantation,cyclophosphamide,ptcy,2010,2017,duration,living,23,months,2-year,incidences,relapse,nonrelapse,mortality,45%,21%,respectively,leukemia-free,lfs,os,graft-versus-host,grfs,34%,42%,27%,highly,influenced,status,being,49%,55%,first,remission,cr1,50%,second,cr,cr2,8%,12%,active,multivariate,negatively,affected,whereas,encouraging,challenging,particularly,when,despite,limitation,small,sample,type,conditioning,calling,into,question,body,irradiation-based,myeloablative,hiv,heavy,drinking,smoking,pro-inflammatory,coronary,heart,chd,interventions,reduce,alcohol,hiv-positive,people,inflammation,varenicline,cytisine,proven,therapies,cessation,consumption,comparative,efficacy,tested,nor,effectiveness,describes,protocol,studying,partial,agonists,ethanol,tobacco,elimination,russians,st,four-arm,parallel-group,randomized,controlled,trial,comparing,nicotine,replacement,therapy,nrt,recruiting,four,hundred,smokers,interested,cutting,down,and/or,petersburg,participants,randomly,assigned,receive,either,varenicline  nrt,placebo,placebo  active,cytisine  nrt,evidence-based,counseling,medication,past,month,primary,craving,2,cigarettes,per,3,7-day,point,prevalence,abstinence,addresses,paucity,guide,here,evaluate,mast,infection,a/h5n1,virus,immunized,mice,cba,intramuscularly,formalin-inactivated,a/vietnam/1194/2004,h5n1nibrg-14,h5n1,samples,7,12,14,21,immunization,infected,intranasally,a/indonesia/5/2005,h5n1idcdc-rg2,half,animals,receiving,mixture,antihistamines,67%,vaccinated,protected,lethality,43%,pbs-immunized,up,85%–95%,immunohistochemical,examination,cd117,staining,lungs,larger,quantity,activated,mock-immunized,histamine,blood,experimental,involvement,they,produce,incomplete,formation,response,vaccination,mismatch,vaccine,gestational,methylazoxymethanol,acetate,mam,produces,offspring,phenotype,relevant,schizophrenia,positive-,negative-like,symptoms,deficits,dopaminergic,dysfunction,abnormalities,show,prenatally,17,display,d3,prefrontal,cortex,pfc,nucleus,accumbens,d2,exclusively,change,perfusion,circle,willis,paralleled,enlargement,lateral,ventricles,detected,resonance,mri,techniques,peripubertal,non-euphoric,phytocannabinoid,cannabidiol,30 mg/kg,postnatal,pnd,19,39,reverse,exposed,i,up-regulation,partially,prevented,haloperidol,06 mg/kg/day,ii,regional,flow,modelling,predicted,bind,preferentially,where,act,agonist,conformation,ionic-lock,conserved,gpcrs,demonstrate,altered,transcript,suggesting,might,contribute,represent,unexplored,target,antipsychotic,timing,immunosuppressive,combination,transplant,haplo-hsct,standardized,schedules,immunosuppression,509,4,tacrolimus,n  215,cyclosporine,csa,mycophenolate,mofetil,mmf,5,n  170,csa  mmf,0,n  124,groups,younger,46,p  02,received,77%,p,,01,regimen,containing,thiotepa,fludarabine,busulfan,84%,44%,48%,59%,15,46%,53%,05,refined,disease-free,rgrfs,33%,39%,36%,grade,ii-iv,gvhd,25%,18%,24%,37%,26%,02,start,hazard,ratio,hr,58,improved,62,administered,improves,pivotal,synucleinopathy,parkinson’s,pd,mediated,neurotoxic,alpha-synuclein,another,dementia,lewy,bodies,dlb,recent,aimed,estimate,plasma,profile,synucleinopathies,pdd,interferon-gamma,ifn-gamma,interleukin,il-4,il-6,il-10,tumor,necrosis,factor,alpha,tnf-alpha,monocyte,chemoattractant,protein-1,mcp-1,estimated,28,individuals,controls,luminex,array,assessed,mini–mental,state,mmse,elevated,p  005,p  0001,p  0026,p  0032,same,differences,pronounced,demetia,metastatic,non-small-cell,lung,cancer,mnsclc,experience,first-,second-line,options,required,arctic,phase,iii,open-label,durvalumab,tremelimumab,versus,care,soc,≥,third-line,comprised,independent,sub-studies,126,≥25%,tcs,expressing,programmed,ligand-1,10 mg/kg,every,weeks,q2w,b,469,tc,3 ,durvalumab ,20,mg/kg ,mg/kg,q4w,then,34,10,q12w,end,points,progression-free,pfs,descriptive,117,063,95%,confidence,interval,ci,042–093,38,22,071,049–104,115,87,080,061–105,p ,0109,077,059–101,0056,treatment-related,3/4,97%,444%,220%,364%,heavily,pretreated,clinically,meaningful,improvements,numerical,profiles,consistent,previous,registration,clinicaltrialsgov,identifier,nct02352948,because,intervals,ris,biochemistry,analytes,matched,population,defined,joined,global,values,rvs,coordinated,ifcc,committee,decision,c-ridl,harmonized,793,healthy,volunteers,recruited,saint-petersburg,moscow,yekaterinburg,variation,explored,regression,partitioning,sex,judged,deviation,anova,latent,abnormal,exclusion,lave,applied,influence,metabolic,inappropriate,sampling,computed,parametric,appreciable,between-city,partition,age-related,especially,females,trend,exaggerated,nutritional,closely,mass,bmi,increases,prominently,bmi  28 kg/m2,excluded,determining,age-specific,effective,lowering,established,biochemical,up-to-date,detailed,consideration,similar,participating,countries,adequate,transplacental,passage,maternal,thyroid,hormone,normal,fetal,growth,overt,hypothyroidism,hyperthyroidism,birthweight,knowledge,gaps,remain,subclinical,function,birthweight—both,third,trimester,pregnancy,examine,associations,individual-participant,meta-analysis,searched,medline,ovid,embase,web,science,cochrane,register,trials,google,scholar,inception,2019,prospective,issued,invitations,identify,authors,join,consortium,pregnancies,in-vitro,fertilisation,pre-existing,usage,miscarriages,stillbirths,sga,neonates,large,newborn,analysed,mixed-effects,models,adjusting,ethnicity,parity,birth,pre-registered,reviews,crd42016043496,2526,published,reports,36,cohorts,met,inclusion,criteria,agreed,participate,five,unpublished,datasets,added,giving,48 145,mother–child,pairs,exclusions,whom,1275,3·1%,stimulating,tsh,free,thyroxine,ft4,929,2·2%,isolated,hypothyroxinaemia,higher,euthyroidism,11·8%,vs,10·0%,adjusted,difference,2·43%,0·43,4·81,odds,1·24,1·04,1·48,p0·015,mean,−38,−61,−15,p0·0015,measurement,7·3%,−2·91,−4·49,−0·88,0·70,0·55,0·91,p0·0073,45,73,p0·0012,sd,6,–10,−2,p0·0030,estimates,women,peroxidase,negative,pinteraction0·10,–25,−17,p0·0001,interpretation,inverse,dose-response,within,advance,understanding,complex,relationships,prompt,careful,risks,benefits,levothyroxine,funding,netherlands,organization,grant,40116020,lorlatinib,third-generation,tyrosine-kinases,inhibitor,tki,targeting,alk/ros1,fusions,fda,approved,tki-pretreated,alk,nsclc,approval,ros1,pending,largest,real-world,harboring,rearrangements,123,enrolled,retrospectively,cut-off,1/1/2019,program,investigator,upon,recist,11,106,8,included,males,never-smokers,metastases,extracranial,ec,intracranial,ic,rates,rr,60,control,dcr,91,88,dot,239  16,mos,891  196,53,65,67,92,78,181  25,903  244,significantly,parameters,edema,48,hyperlipidemia,47,weight,gain,25,fatigue,1–2,shows,outstanding,ec/ic,89  19,supports,90  24,unprecedented,diabetes,mellitus,dysregulation,complications,suffer,diabetic,polyneuropathy,involves,presence,nerve,synthetic,arginine-rich,exendin-4,peptide,d,caused,neuropathy,induced,administering,streptozotocin,stz,10 μg/kg,byetta®,1 μg/kg,80,neuropathic,pain,tactile,allodynia,stz-treated,showed,unlike,naïve,histological,diameter,sciatic,fibers,smaller,ihc,myelin,mbp,resulted,myelinated,poly-arginine,peptides,promising,polyneuropathies,pattern,auditory,preterm,children,longitudinal,271,aged,old,divided,70,32–36,201,22–31,hearing,abr,assr,oae,audiometry,pure,tone,additionally,some,ct,gbj2,evaluations,assessments,3–4,times,year,under,2–3,over,infants,problems,examined,annual,snhl,ansd,257%,64,318%,occurrence,assessment,child,kinds,noted,loss,transformation,vice,versa,discussed,article,prematurely,born,tends,unstable,deteriorate,improve,before,weeks’,gestation,require,least,until,caution,advised,cochlear,implantation,32,introduction,single-arm,ascend-3,ceritinib,anaplastic,lymphoma,kinase,alki–naive,alk-rearranged,lines,chemotherapy,final,eligible,asymptomatic,neurologically,stable,oral,750,mg/day,fasted,investigator-assessed,orr,secondary,blinded,committee–assessed,investigator-,patient-reported,124,984%,antineoplastic,medications,250%,regimens,49,395%,baseline,cutoff,january,521,484–601,677%,588–759,166,110–232,513,427–553,grades,≥60%,all-causality,diarrhea,855%,nausea,782%,vomiting,718%,145%,event,discontinuation,health-related,quality,maintained,chemotherapy-pretreated,alki-naive,possibilities,angioprotection,osteonecrosis,given,bisphosphonates,experiment,27,injected,saline,zoledronic,acid,doses,sulodexide,constructed,teeth,extracted,velocity,linear,periodontal,area,tooth,high-frequency,doppler,ultrasound,vasoactive,substance,acetylcholine,3%,1min,structure,bony,tissues,head,microcirculation,mucous,membranes,greater,extent,tissue,causes,periosteal,includes,cellular,component,endothelium-dependent,vasodilation,membrane,vessels,reducing,restoration,reduces,subcortical,pathways,motor,spinal,cord,injury,sci,animal,descending,interlimb,lumbosacral,excitability,humans,ulnar,transcutaneous,condition-test,paradigm,connections,linking,cervical,segments,non-injured,n15,injured,n18,spinally,evoked,responses,semrs,7/7,volitional,leg,muscle,activation,6/11,rostral,innervation,entry,zones,modulation,pools,via,projections,exist,absence,significance,sub-clinical,spared,residual,rehabilitation,macrophages,regulation,morphogenetic,placenta,roles,unclear,placental,hofbauer,characterize,steps,production,intracellular,synthesis,secretion,compare,secretory,villous,placentas,9–12,38–40,determined,cytometry,secreted,quantified,cytometric,bead,patterns,il-1,il-8,tnfα,basal,stimulated,endotoxin,il-11,il-17a,il-17f,tgf-β,vegf,constitutive,did,respond,age-dependent,il-17,third-trimester,first-trimester,comparison,suggested,intraplacental,extraplacental,discussion,would,safe,assume,correspond,attenuated,supposedly,local,confined,mutations,glucocerebrosidase,gba,cause,gaucher,gd,lysosomal,storage,disorder,lsd,parkinson's,lysosome,functionality,plays,extracellular,vesicles,evs,content,terms,amounts,cargo,sequential,centrifugation,сryo-electron,microscopy,cryo-em,nanoparticle,tracking,nta,light,scattering,dls,exosomal,hsp70,tetrasponins,profiling,mass-spectrometry,shotgun,morphology,exosomes,derived,р00001,confirmed,mode,p  002,double,multilayer,enriched,surface,cd9,сd63,cd81,exosome-associated,proteomic,proteins,thus,striking,alteration,perform,postural,neuropsychiatric,tremor,et,phenotypes,combined,et-pd,169,10–20,111,advanced,25–30,hoehn,yahr,scale,26,non-motor,stabilometry,etpd,milder,parkinsonism,posture,walking,discovered,indexes,stabilometric,although,helpful,helps,expand,highlighted,autophagy,pathway,alp,genes,lrrk2,harbor,α-synuclein,encoded,snca,degraded,mainly,mutations/multiplications,chaperone,functions,pd-related,prkn,pink1,tmem175,smpd1,ctsd,ctsb,relationship,crucial,uncovering,long-awaited,neuroprotective,will,atypical,forms,elucidate,dynamical,complexity,impulse,sensory,neurons,emergence,antinociceptive,painful,stimulus,solve,problem,bifurcation,enabled,us,relations,nociceptive,neuron,shown,mechanism,suppression,ectopic,bursting,discharges,base,potassium,blocking,connected,entirely,modification,gating,nav18,sodium,channels,action,comenic,non-opioid,analgesic,anoceptin,explain,metoclopramide,widely,abortive,migraine,advantage,having,antiemetic,anti-cephalalgic,elucidated,taking,account,key,trigeminovascular,pathophysiology,investigate,neurogenic,dural,valid,electrophysiological,neurovascular,nociception,recordings,second-order,dura-sensitive,trigeminocervical,tcc,anaesthetised,cumulative,infusion,30 min,5 mg/kg,iv,step,n  8,dose-dependently,suppressed,firing,maximally,30%0–49%,medianq1-q3,4%0–30%,p  0001,contrast,separate,n  6,vehicle,p  005,unable,does,suppress,anti-migraine,neurophysiological,therapeutic,lipopolysaccharidein,affects,disturbances,disrupts,metabolism,immunoassay,biological,dynamics,simulation,checkpoints,predictor,tms/tes,eight-year,european,society,party,drinkers,daily,degranulation,release,influenza-sensitized,reversed,behalf,synucleinophaties,cancer☆,establishing,major,part,glass,real,exenatide,premature,of ceritinib,bisphosphonate,instability,overlapping,genetics
ВСТРЕТИЛОСЬ РАЗ в файле 2020.txt,32,5,242,1,2,24,4,6,388,5,369,6,319,1,4,8,5,10,11,2,37,14,4,3,3,3,3,4,9,40,4,33,3,11,14,4,3,9,3,86,2,2,2,3,4,2,2,4,41,2,11,1,1,1,1,1,4,1,37,1,4,6,2,2,28,22,1,3,20,7,84,1,1,1,8,31,1,14,2,2,13,1,1,1,2,3,2,76,10,8,1,1,1,9,1,2,5,2,1,6,2,1,2,7,1,1,1,1,1,2,3,48,7,8,5,1,2,3,12,15,1,1,2,2,7,8,1,2,1,2,6,129,2,4,15,3,1,7,4,1,5,2,4,1,3,32,24,16,5,1,7,1,1,5,2,5,21,85,1,2,4,1,1,10,2,11,5,7,1,2,2,1,8,1,7,1,3,1,1,11,3,18,4,27,2,3,2,3,2,1,141,1,1,11,13,1,6,1,1,6,1,7,1,1,1,1,1,1,4,4,1,2,2,1,2,5,5,8,1,1,15,2,2,1,8,1,1,3,3,1,1,25,2,2,1,1,1,3,6,18,1,3,5,1,1,3,2,1,1,1,4,2,13,5,1,1,5,8,2,5,4,2,2,2,1,1,8,2,2,1,2,4,3,3,1,1,2,1,1,2,8,6,2,22,10,1,11,3,1,10,1,1,2,1,4,1,4,3,1,1,2,1,1,1,2,1,7,7,6,1,1,1,1,10,11,1,14,2,3,5,1,1,8,1,1,16,1,3,2,6,6,1,2,2,5,1,2,1,1,1,1,1,6,4,2,1,1,2,8,4,1,2,6,2,2,4,3,2,1,2,1,1,4,1,3,3,1,3,10,1,1,2,2,1,1,3,1,1,1,1,1,6,1,7,1,10,4,3,1,3,3,1,18,1,1,2,6,3,2,1,1,11,1,2,1,1,17,1,1,1,1,1,2,1,4,1,4,1,1,2,3,1,7,5,2,2,1,1,12,1,1,1,1,2,1,1,1,1,1,4,1,2,1,1,5,1,1,1,1,4,2,1,9,1,1,3,1,1,1,4,2,1,2,3,1,2,1,1,1,1,7,3,1,1,2,1,1,1,1,1,1,1,8,2,1,1,1,1,1,6,1,7,1,3,2,3,2,1,1,1,4,6,1,7,2,1,1,3,1,3,4,1,14,5,6,3,5,7,2,3,72,2,3,3,22,2,8,2,7,1,1,2,1,2,1,2,1,2,5,2,1,2,3,4,7,3,3,14,1,1,1,7,8,8,1,1,1,5,1,1,2,1,2,2,2,14,4,1,1,5,33,11,1,1,1,1,14,3,1,1,4,4,2,1,1,9,1,6,1,1,3,1,5,12,6,1,1,1,9,10,3,7,1,1,1,4,2,1,4,1,2,1,1,1,1,1,3,1,3,3,4,1,1,1,1,1,1,2,1,2,1,4,1,1,1,3,3,1,1,2,3,3,6,4,1,3,1,1,3,7,4,3,1,8,1,2,4,2,1,2,3,1,1,1,1,1,1,1,2,1,2,2,2,1,1,1,4,1,2,5,1,1,1,1,1,2,2,1,2,1,1,1,1,1,1,5,3,10,1,1,1,1,1,1,1,1,1,1,1,7,6,2,1,1,1,1,1,1,2,2,1,3,1,1,1,1,1,1,1,1,2,1,1,2,9,1,1,1,1,1,1,1,1,1,1,1,2,1,3,5,2,2,8,4,5,2,2,3,5,5,7,9,3,4,1,6,1,1,1,1,1,5,6,2,2,23,1,2,2,1,4,4,1,1,1,3,5,2,1,1,1,20,1,1,2,3,1,5,12,1,1,2,3,1,1,2,5,4,4,2,2,3,2,5,3,1,1,2,1,3,2,1,5,8,2,1,1,4,7,1,2,3,2,1,2,2,1,3,1,4,1,2,1,1,5,1,1,1,1,1,2,4,1,1,1,1,1,1,1,1,1,2,2,2,3,1,1,2,2,1,1,1,1,1,1,1,1,2,2,1,1,1,1,5,2,6,1,5,1,4,3,1,2,1,2,1,1,1,4,2,1,1,2,1,1,2,1,1,1,1,3,1,6,1,1,1,1,1,1,1,1,1,1,4,5,2,1,2,2,4,2,1,1,1,1,1,3,1,1,6,1,1,1,2,3,1,1,1,4,1,1,1,2,1,2,7,2,1,2,2,5,2,6,1,1,4,1,1,1,2,1,1,2,2,2,3,2,1,2,1,12,3,3,3,3,4,4,8,1,1,4,1,1,19,3,1,2,2,3,1,3,11,2,8,13,2,1,2,1,1,3,2,3,1,1,1,8,1,1,2,6,2,2,1,1,5,2,2,5,4,1,1,1,2,3,1,2,1,2,5,1,4,1,2,1,1,4,5,4,8,1,1,1,3,1,4,8,4,1,2,4,4,2,2,2,3,4,8,2,2,1,1,3,1,2,1,1,3,1,1,4,1,1,6,4,4,2,1,1,9,3,1,2,1,3,1,1,1,2,2,7,1,1,2,3,1,3,2,1,1,1,2,1,1,4,1,15,1,3,10,1,2,1,1,1,1,1,8,3,4,5,2,2,3,7,1,1,1,1,1,2,2,1,5,2,2,1,1,1,1,1,1,4,2,1,2,1,1,1,1,2,1,3,1,1,4,1,2,2,1,1,1,1,3,12,1,2,4,1,1,1,15,1,1,1,10,1,1,6,1,1,4,1,3,1,1,4,1,1,4,2,2,1,3,1,7,1,1,2,1,1,3,1,1,1,1,1,1,1,1,1,4,1,2,1,2,1,1,5,1,1,2,3,1,1,2,1,1,1,1,1,1,3,1,7,1,1,1,1,1,1,1,1,1,1,1,1,4,1,1,1,3,1,1,1,1,3,1,1,1,3,3,1,3,1,1,1,1,1,1,1,1,1,5,1,2,1,1,8,1,1,3,5,1,9,5,4,1,1,1,1,1,1,1,1,1,5,1,1,1,1,1,3,1,2,2,4,1,2,4,1,1,1,2,2,2,2,4,6,1,2,3,2,2,1,2,2,29,2,1,1,1,7,1,1,6,2,2,3,13,3,3,6,1,2,1,2,4,4,2,1,2,1,3,1,1,1,2,1,1,2,8,1,2,7,1,1,1,1,2,3,1,1,2,2,3,1,2,2,2,1,3,1,1,1,1,2,3,3,1,1,11,9,8,1,12,1,2,1,3,1,1,2,1,1,1,1,1,1,14,3,4,1,3,1,5,1,1,4,2,2,3,3,1,4,3,2,8,1,1,1,8,2,2,8,1,1,2,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,2,2,2,1,2,2,5,1,1,1,1,3,4,7,2,7,2,4,2,1,3,4,6,1,2,1,1,2,1,1,1,2,2,1,1,1,2,1,2,1,3,1,1,1,1,1,1,2,1,3,2,1,2,2,1,1,1,1,1,2,1,1,1,2,1,1,3,2,1,1,2,1,2,1,1,1,2,1,1,2,1,1,2,1,1,1,11,11,2,6,3,1,1,4,1,12,1,1,2,4,10,1,3,3,6,1,1,3,2,1,1,1,1,1,1,1,2,1,1,1,1,1,4,1,1,1,2,1,1,2,1,1,1,1,1,1,5,2,1,1,1,1,3,1,1,1,3,1,1,1,1,1,2,1,3,1,1,2,1,2,1,1,1,2,1,1,1,1,1,1,1,1,1,4,1,1,4,1,1,5,3,7,2,1,2,2,2,7,1,1,1,1,1,1,1,1,5,1,1,1,1,2,1,1,1,1,1,1,1,1,1,2,1,2,2,1,1,1,1,2,1,1,1,1,1,1,1,1,1,2,1,4,3,1,1,1,1,1,1,1,1,1,1,1,6,1,1,2,1,1,3,1,1,1,1,7,9,1,5,1,1,1,1,1,2,4,1,1,1,1,1,1,1,1,1,3,2,2,2,4,1,2,2,2,2,2,1,3,2,1,1,3,1,4,1,1,2,1,1,1,1,1,3,3,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,4,2,1,2,1,5,1,1,3,7,1,2,1,5,5,1,2,1,1,1,1,1,3,1,1,2,2,3,3,2,3,1,3,1,2,3,2,2,1,1,2,1,1,1,1,1,1,1,4,3,17,1,1,2,1,2,1,1,1,1,8,1,1,1,2,1,1,1,2,1,1,1,1,2,4,4,3,2,1,3,1,1,1,2,3,1,1,1,1,2,1,1,1,1,1,1,1,2,1,1,3,1,1,1,1,3,1,5,1,4,1,1,1,1,1,1,2,1,2,4,1,1,1,1,2,3,1,2,1,1,1,1,1,1,1,1,2,3,1,2,2,1,1,1,1,1,2,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,3,3,1,1,1,1,3,5,6,1,3,1,1,2,1,1,1,1,1,1,1,1,1,2,1,1,1,1,3,2,1,4,4,3,1,1,5,1,1,1,2,1,1,3,1,1,1,1,1,1,3,7,6,4,3,7,1,2,4,4,2,1,3,1,1,1,1,2,1,1,1,1,1,1,2,2,3,2,1,3,2,2,6,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,11,1,2,1,5,1,8,1,1,2,8,2,1,4,1,1,2,1,1,1,1,2,1,1,1,1,6,1,2,2,2,1,1,2,1,1,1,1,1,2,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,2,1,2,1,2,6,4,1,1,1,4,1,1,1,2,2,5,1,1,1,1,1,1,1,1,3,1,1,2,1,1,2,3,2,1,2,1,1,2,4,1,1,1,1,1,1,1,1,1,1,1,1,1,1,3,2,1,1,1,3,2,2,8,1,1,5,1,1,1,3,1,1,1,1,1,1,2,4,1,2,1,1,1,2,2,1,1,1,1,1,3,2,8,5,1,1,1,1,2,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,3,1,1,1,3,3,1,2,6,3,3,1,1,1,1,1,1,1,1,2,1,1,6,3,1,1,2,1,1,1,1,2,1,1,1,1,1,4,1,1,3,1,1,8,1,1,4,1,1,1,1,1,1,1,1,5,1,1,2,3,1,1,1,2,1,1,1,1,2,1,2,2,1,2,2,2,2,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,2,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1
